BIOBIJOU Co.,Ltd. (489460.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea · ISIN KR7489460006

Price
13,010.00 KRW
Market cap
195.73 bn KRW
P/E (2025)
47.14
P/S (2025)
6.87
Dividend yield
0.77 %
Net margin
14.57 %
Return on equity (ROE)
6.70 %
Return on assets (ROA)
6.51 %

BIOBIJOU Co.,Ltd. financials

Fiscal year20242025
Revenue29.63 bn KRW28.49 bn KRW
Gross profit14.85 bn KRW15.92 bn KRW
Operating income9.23 bn KRW4.23 bn KRW
EBIT9.42 bn KRW5.04 bn KRW
Net income7.19 bn KRW4.15 bn KRW
Diluted EPS – continuing operations477.80 KRW275.98 KRW

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About BIOBIJOU Co.,Ltd.

BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin. It also exports its products to Iraq, the Dominican Republic, Turkey, China, Vietnam, Hong Kong, Russia, Malaysia, the United Kingdom, CIS, and Colombia. The company was founded in 2018 and is based in Hanam-si, South Korea. BIOBIJOU Co.,Ltd. is a subsidiary of CHUNGDAMGLOBAL Co., Ltd.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.